Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 10.64 USD 6.08% Market Closed
Market Cap: 741.1m USD

Wall Street
Price Targets

PHAT Price Targets Summary
Phathom Pharmaceuticals Inc

Wall Street analysts forecast PHAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHAT is 17.98 USD with a low forecast of 5.05 USD and a high forecast of 29.4 USD.

Lowest
Price Target
5.05 USD
53% Downside
Average
Price Target
17.98 USD
69% Upside
Highest
Price Target
29.4 USD
176% Upside
Phathom Pharmaceuticals Inc Competitors:
Price Targets
4516
Nippon Shinyaku Co Ltd
20% Upside
IMP
Imexpharm Corp
8% Downside
CPH
Cipher Pharmaceuticals Inc
25% Upside
AHEALTH
Apex Healthcare Bhd
25% Upside
COPN
Cosmo Pharmaceuticals NV
69% Upside
HYPE3
Hypera SA
7% Downside
HITI
High Tide Inc
125% Upside
3933
United Laboratories International Holdings Ltd
7% Downside

Revenue
Forecast

Revenue Estimate
Phathom Pharmaceuticals Inc

The compound annual growth rate of Phathom Pharmaceuticals Inc's revenue for the next 3 years is 115%.

N/A
Past Growth
115%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Phathom Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Phathom Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHAT's stock price target?
Price Target
17.98 USD

According to Wall Street analysts, the average 1-year price target for PHAT is 17.98 USD with a low forecast of 5.05 USD and a high forecast of 29.4 USD.

What is Phathom Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
115%

The compound annual growth rate of Phathom Pharmaceuticals Inc's revenue for the next 3 years is 115%.

Back to Top